You searched for Dermal microvascular endothelial cells

Toxic Antiseptic Agents and Searching for New Treatments for Psoriasis

Anatomy of the Skin, the Body’s Largest Organ The skin is the largest organ in the human body and is the largest area in contact with the external environment. In addition to providing physical protection, the skin also regulates body temperature and provides sensory information. As a result, it must be resilient enough to survive…

March 15, 2019 by Lifeline® Cell Technology

Keratinocytes

Herpes Simplex Virus, Nerve Damage; Melanoma, Tumor Pathogenesis

Anatomy of the Skin The skin is composed of three layers: epidermis, dermis, and hypodermis. The epidermis is the outermost layer of the skin and is primarily composed of keratinocytes, the cells from which basal cell carcinoma develop. As keratinocytes mature, they become post-mitotic and lose their nucleus, becoming corneocytes, which are eventually shed from…

December 7, 2018 by Lifeline® Cell Technology

FrostaLife ™ Cryopreservation Solution — 100 mL

FrostaLife™ is a solution optimized for the cryopreservation of Primary Mammalian Cells by Lifeline® cell culture experts. Simply count your cells, centrifuge them and resuspend the cell pellet in the desired volume of FrostaLife and dispense into cryopreservation vials. FrostaLife is a ready-to-use 100 mL freezing reagent containing DMSO and fetal bovine serum. FrostaLife contains…

September 1, 2015 by Lifeline® Cell Technology

Fibroblasts

Human iPSC-Derived Organoid Model to Study the Neuropathology of HIV-1

Human immunodeficiency virus (HIV) affects an estimated 38 million people worldwide with nearly 1.6 million new infections every year. Despite the availability of combined antiretroviral therapy (cART), a significant percentage of people with HIV will develop neurological deficits. The lack of suitable in vitro models that can accurately recapitulate the human brain has hindered the…

August 9, 2024 by Lifeline® Cell Technology

Lifeline Cells and Media

Drug Repurposing to Treat COVID-19 Induced Lung Injury

The rapid spread of COVID-19 during the global pandemic has led many scientists and researchers to look towards repurposing existing FDA-approved drugs, outside the scope of their originally designated purposes, to expedite the delivery of effective treatments on the shortened time-scale required to treat COVID-19 patients owing to their proven safe for human use in…

October 1, 2021 by Lifeline® Cell Technology

Cell Culture Medium

Promising New Candidate to Treat Influenza Infections

A Better Drug Candidate to Treat Influenza Infections Influenza viruses are responsible for over 600,000 deaths globally and have a huge impact on human health and productivity. However, the moderate efficacy of influenza vaccines means that many individuals, particularly the elderly, still develop influenza infections even with vaccination. Current drug treatments for influenza infections include…

April 15, 2021 by Lifeline® Cell Technology

Cell Culture Medium

Quality Data Relies on Quality Reagents

The ability to culture cells in vitro has provided scientists with insight into many tissue and organ systems in the human body. In order to obtain high quality, reliable results, it is imperative that experiments are conducted using high-quality cell culture reagents. Of critical importance is the quality of cell culture media to ensure the…

October 1, 2020 by Lifeline® Cell Technology

Primary Cells, Stem Cells, and Optimized Media for Research

Search Results